NO20043860L - Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike - Google Patents

Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike

Info

Publication number
NO20043860L
NO20043860L NO20043860A NO20043860A NO20043860L NO 20043860 L NO20043860 L NO 20043860L NO 20043860 A NO20043860 A NO 20043860A NO 20043860 A NO20043860 A NO 20043860A NO 20043860 L NO20043860 L NO 20043860L
Authority
NO
Norway
Prior art keywords
carrier
custodian
carrier materials
agent
manufacture
Prior art date
Application number
NO20043860A
Other languages
English (en)
Norwegian (no)
Inventor
Gabriele Reich
Berthold Kohler
Original Assignee
Stoess & Co Gelatine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoess & Co Gelatine filed Critical Stoess & Co Gelatine
Publication of NO20043860L publication Critical patent/NO20043860L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593Polyesters, e.g. PLGA or polylactide-co-glycolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20043860A 2002-02-16 2004-09-15 Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike NO20043860L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10206517A DE10206517A1 (de) 2002-02-16 2002-02-16 Depotarzneimittel, Trägermaterialien für Depotarzneimittel und Verfahren zu deren Herstellung
PCT/EP2003/000725 WO2003068192A1 (de) 2002-02-16 2003-01-24 Depotarzneimittel, trägermaterialien für depotarzneimittel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
NO20043860L true NO20043860L (no) 2004-09-15

Family

ID=27674694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043860A NO20043860L (no) 2002-02-16 2004-09-15 Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike

Country Status (17)

Country Link
EP (1) EP1474110B1 (pl)
AT (1) ATE369123T1 (pl)
AU (1) AU2003210181A1 (pl)
BR (1) BR0307675A (pl)
DE (2) DE10206517A1 (pl)
DK (1) DK1474110T3 (pl)
EA (1) EA006988B1 (pl)
ES (1) ES2289304T3 (pl)
HU (1) HUP0500119A3 (pl)
IL (2) IL162868A0 (pl)
MX (1) MXPA04006982A (pl)
NO (1) NO20043860L (pl)
NZ (1) NZ533103A (pl)
PL (1) PL371785A1 (pl)
PT (1) PT1474110E (pl)
WO (1) WO2003068192A1 (pl)
ZA (1) ZA200403979B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060682A1 (it) * 2006-12-19 2008-06-20 Sicit Chemitech S P A Nuovi derivati polimerici biodegradabili
DE102007011606A1 (de) 2007-03-02 2008-09-04 Carl Freudenberg Kg Faser-Wirrgelege
US12520859B2 (en) 2020-01-13 2026-01-13 Cargill, Incorporated Turkey collagen hydrolysates and methods of making

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
CA2214889C (en) * 1995-03-10 2005-05-24 Hans Koll Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and a process for the production thereof
DE19813174A1 (de) * 1998-03-25 1999-05-27 Schering Ag Mikropartikel aus Polymeren und mindestens einer gerüstbildenden Komponente und ihre Herstellung und Verwendung in der Ultraschalldiagnostik und zur ultraschallinduzierten Wirkstofffreisetzung
US6384105B1 (en) * 1999-04-16 2002-05-07 William Marsh Rice University Poly(Propylene Fumarate) cross linked with Poly(Ethylene Glycol)

Also Published As

Publication number Publication date
IL162868A (en) 2008-03-20
EP1474110A1 (de) 2004-11-10
EA006988B1 (ru) 2006-06-30
MXPA04006982A (es) 2004-11-10
HUP0500119A2 (hu) 2005-07-28
ATE369123T1 (de) 2007-08-15
PT1474110E (pt) 2007-10-01
WO2003068192A1 (de) 2003-08-21
DE10206517A1 (de) 2003-09-04
IL162868A0 (en) 2005-11-20
BR0307675A (pt) 2005-01-11
EP1474110B1 (de) 2007-08-08
NZ533103A (en) 2007-04-27
ZA200403979B (en) 2004-11-29
PL371785A1 (pl) 2005-06-27
HUP0500119A3 (en) 2008-04-28
ES2289304T3 (es) 2008-02-01
DK1474110T3 (da) 2007-12-10
AU2003210181A1 (en) 2003-09-04
EA200401012A1 (ru) 2005-04-28
DE50307874D1 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
Buffat Synthesis of piperidines
DE60018600D1 (de) Bioaktiver abbaubarer verbundstoff für "tissue engineering"
IL173078A0 (en) Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
DE602006014692D1 (de) Film mit reinigungsmittel
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DE60034819D1 (de) Hydroxy-phenoxyetherpolymere in der papierherstellung
MXPA03003473A (es) Metodos para producir compuestos de oxazolidinona.
NZ591802A (en) Oral and personal care compositions and methods
CA2476622A1 (en) A transdermal patch
WO2004100857A3 (en) Highly plastic granules for making fast melting tablets
MY134275A (en) Multi-layer film and medicine container using the same
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
ATE378042T1 (de) Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
DE60305438D1 (de) Lyophilisierte pharmazeutische zusammensetzung von propofol
DE50206912D1 (de) Verfahren zur kontinuierlichen herstellung und beschichtung von selbstklebemassen auf basis von sbc mit mindestens einem pharmazeutischen wirkstoff
ATE441359T1 (de) Stethoskop
NO20043860L (no) Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike
ATE332799T1 (de) Verfahren und vorrichtungen zur herstellung von faserverstärkten bauteilen
AU2067802A (en) Polycarbonate composite material which can be thermoplastically shaped, methods for the production thereof, use of the same and a flame-proof polycarbonate moulded part
ES2065688T3 (es) Contenedor y procedimiento para su fabricacion.
AU6308700A (en) Method and apparatus for producing improvised music
ATE411051T1 (de) Polypeptid, dessen konjugat doxorubicin enthält, und auf diesem basierende pharmazeutische zusammensetzung
DE602005009734D1 (de) Ial und thermoplastischem oder elastomerem material und verfahren zur herstellung des artikels
SG153663A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports
GB2409661A (en) Composite materials

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application